To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses here.
For more information on this topic, please visit the Real Time Learning Network
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
These webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here. The agenda and details are below.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
Updates in COVID-19 Treatment and Antibody-Based Prevention
Overview
Rajesh Gandhi, MD, FIDSA
Director, HIV Clinical Services and Education
Massachusetts General Hospital
Co-Director, Harvard Center for AIDS Research
Professor of Medicine, Harvard Medical School
Chair, HIV Medicine Association
Treatment of the Immunocompromised Patient — Case Presentation
Arthur Yu-Shin Kim, MD
Associate Professor of Medicine, Harvard Medical School
Associate Physician, Massachusetts General Hospital
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Treatment in the Era of Oral Antivirals
Annie Luetkemeyer, MD
Professor of Medicine
Division of HIV, Infectious Diseases and Global Medicine
Zuckerberg San Francisco General Hospital
University of California San Francisco
